59
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Continuous Flumazenil for Zolpidem Toxicity-Commentary

Pages 745-746 | Published online: 29 Jul 2009

References

  • Burton J H, Lyon L, Dorfman T, Tomassoni A J. Continuous flumazenil infusion in the treatment of Zolpidem (Ambien®) and ethanol coingestion. J Toxicol Clin Toxicol 1998; 36: 743–744
  • Lheureux P, Debailleul G, De Witte O, Askenasi R. Zolpidem intoxication mimicking narcotic overdose: Response to flumazenil. Hum Exp Toxicol 1990; 9: 105–107
  • Garnier R, Guerault E, Muzard D, Azoyan P, Chaumet-Riffaud A E, Efthymiou M L. Acute Zolpidem poisoning. Analysis of 344 cases. J Toxicol Clin Toxicol 1994; 32: 391–404
  • Höjer J, Baerhendtz S, Magnusson A, Gustafson L L. A placebo controlled trial of flumazenil given by continuous infusion in severe benzodiazepine overdosage. Acta Anaestesiol Scand 1991; 35: 584–590
  • Gueye P, Taboulet P, Metadier de Saint Denis D. Utilisation rationnelle du flumazenil devant'un trouble de conscience de Fadulte. Réanimaton des Intoxications Aiqües., F Baud. Masson, Paris 1995; 79–87
  • Gueye P N, Lofasso F, Mellerio F, Harf A, Vicaut E, Baud F J. Effet des faibles doses de flumazenil sur les resistances des voies aeriennes supérieures et le travail respiratoire au cours des intoxications aiguës pures ou prédominates par benzodiazépines (abstract). Réan Urg 1996; 5: 816

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.